Mepolizumab, a humanized anti-IL-5 mAb, as a treatment option for severe nasal polyposis
Keywords: Anti-IL-5; mepolizumab; eosinophils; chronic rhinosinusitis; nasal polyposis; AC; Available case analysis; AUC; Area under the curve; CFB; Change from baseline; CRSsNP; Chronic rhinosinusitis without nasal polyps; CRSwNP; Chronic rhinosinusitis with nas